CSPC PHARMACEUT.GR. ADR4 (CVGU) — Capital Reinvestment Ratio
CSPC PHARMACEUT.GR. ADR4 (CVGU) has a Capital Reinvestment Ratio of 0.39x as of December 2025, meaning it reinvests 0% of its operating cash flow (€5.83 Billion) in capital expenditures (€2.28 Billion). Check CSPC PHARMACEUT.GR. ADR4 tangible book value ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
CSPC PHARMACEUT.GR. ADR4 Capital Reinvestment Ratio (2021–2025)
This chart tracks CSPC PHARMACEUT.GR. ADR4's Capital Reinvestment Ratio across 5 annual periods. For the full cash flow conversion analysis, see CSPC PHARMACEUT.GR. ADR4 (CVGU) cash conversion ratio.
Annual Capital Reinvestment Ratio for CSPC PHARMACEUT.GR. ADR4 (2021–2025)
Year-by-year Capital Reinvestment Ratio for CSPC PHARMACEUT.GR. ADR4 from 2021 to 2025. See CSPC PHARMACEUT.GR. ADR4 (CVGU) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (EUR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.39x | €5.83 Billion | €2.28 Billion | ▼ -33.8% |
| 2024 | 0.59x | €4.53 Billion | €2.68 Billion | ▲ +30.4% |
| 2023 | 0.45x | €4.18 Billion | €1.89 Billion | ▲ +26.9% |
| 2022 | 0.36x | €7.63 Billion | €2.72 Billion | ▼ -5.9% |
| 2021 | 0.38x | €4.64 Billion | €1.76 Billion | — |